Results 91 to 100 of about 3,830 (166)

TLR4: A Potential Therapeutic Target in the Experimental Pathogenesis of Hemolytic-Uremic Syndrome. [PDF]

Int J Mol Sci
Varrone E, Pepe V, Storci G, Bonafè M, Brunetti B, Brigotti M.   +5 more
europepmc   +1 more source

Fabry Disease: Integrating Molecular Pathophysiology, Precision Diagnosis, and Artificial Intelligence Toward Precision Medicine. [PDF]

Cells
Biddeci G, Spinelli G, Colomba P, Anania M, Duro G, Di Blasi F.   +5 more
europepmc   +1 more source

Historical Control Analysis Demonstrates Greater Long-Term Reduction in Plasma Globotriaosylceramide (Gb3) by Venglustat Compared With Placebo or Agalsidase Beta in Male Patients With Classic Fabry Disease. [PDF]

Mol Genet Genomic Med
Germain DP, DasMahapatra P, Liu S, Deegan P, Ortiz A, Modur V, Wilcox WR.   +6 more
europepmc   +1 more source

Hydroxychloroquine-induced renal phospholipidosis manifesting as proximal tubulopathy in systemic lupus erythematosus. [PDF]

BMC Nephrol
Manabe S, Seki M, Ushio Y, Ochiai M, Takahashi R, Kobayashi S, Makabe S, Ito N, Kataoka H, Taneda S, Honda K, Nitta K, Hoshino J.   +12 more
europepmc   +1 more source

Modeling Fabry nephropathy: insights from experimental systems towards precision nephrology. [PDF]

Dis Model Mech
Elsaid H, Furriol J, Eikrem Ø, Tøndel C, Svarstad E.   +4 more
europepmc   +1 more source

Clinical awareness and targeted manual urine microscopy enable diagnosis of a fabry disease family missed by routine urinalysis. [PDF]

BMC Nephrol
Kato H, Yokoyama T, Manabe S, Seki M, Ushio Y, Makabe S, Kobayashi S, Kataoka H, Nitta K, Hoshino J.   +9 more
europepmc   +1 more source

VCAM-1 as a biomarker of early cardiac phenotypic changes in Fabry disease. [PDF]

BMC Cardiovasc Disord
Lino DODC, Meneses GC, de Almeida IM, Martins AMC, Vasconcelos AJS, de Lima CJM, Rocha RPS, Daher EF, da Silva Junior GB.   +8 more
europepmc   +1 more source

Evaluating the relationship between antidrug antibodies and efficacy and safety outcomes in patients with Fabry disease receiving enzyme replacement therapy: a systematic literature review. [PDF]

Orphanet J Rare Dis
Aguiar P, Bernat JA, Hughes D.
europepmc   +1 more source

Correction: Globotriaosylceramide Accumulation and Not Alpha-Galactosidase-A Deficiency Causes Endothelial Dysfunction in Fabry Disease.

PLoS ONE, 2012
Mehdi Namdar, Catherine Gebhard, Rafael Studiger, Yi Shi, Pavani Mocharla, Christian Schmied, Pedro Brugada, Thomas F. Lüscher, Giovanni G. Camici   +8 more
doaj   +1 more source

Autophagy-Lysosomal Dysfunction as a Converging Mechanism of Cardiomyopathy in Lysosomal Storage Disorders: From Pathobiology to Targeted Therapy. [PDF]

Int J Mol Sci
Lee CL, Chuang CK, Chang YH, Chiu HC, Tu YR, Lo YT, Wu JY, Lin HY, Lin SP.   +8 more
europepmc   +1 more source